European nod for Sanofi drugs
November 19, 2012Research and Development, Sales and Marketing CHMP, Sanofi
Two of Sanofi’s key drugs have cleared the penultimate hurdle to approval in Europe with a recommendation from the CHMP. …
Daiichi Sankyo chief executive elected NPC chairman of the Board
November 19, 2012Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo
The National Pharmaceutical Council (NPC) has announced that Daiichi Sankyo president and chief executive John Gargiulo has been elected chairman …
Implementation of IHW ‘patchy’
November 16, 2012Sales and Marketing CCGs, IHW, NHS
An NHS initative which is supposed to drive public health forward is in danger of having only a limited impact, …
The future is bright – but don’t rely on emerging markets
November 16, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, emerging markets, industry, pwC
The pharma industry could be “on the cusp of a golden era” of renewed productivity and earnings – but only …
Sanofi appoints Gary Nabel as chief scientific officer
November 16, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabel, Sanofi
Sanofi has announced the appointment of Dr Gary Nabel, senior VP, chief scientific officer and deputy to the president for …
EFPIA rejects ‘indiscriminate’ transparency
November 16, 2012Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials
Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …
Orchid exits Chinese joint venture
November 15, 2012Manufacturing and Production North China pharma corp, Orchid
India’s Orchid Chemicals & Pharmaceuticals has ducked out of a joint venture it set up in China ten years ago …
Jeff Jonas joins Shire’s Leadership Team
November 15, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeff Jonas, Shire
Shire has announced that Jeff Jonas has been appointed president of Shire’s Regenerative Medicine (RM) business and will join the …
UK Board appointments at Universal WorldEvents
November 15, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents
Healthcare events firm Universal WorldEvents has appointed Denise Abbott and Nicola Burns to its Board. Abbott (pictured) joined Universal WorldEvents …
Forxiga approved in European Union
November 15, 2012Sales and Marketing AstraZeneca, BMS, Forxiga, diabetes
AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga has been approved in Europe – a major filip for …
Regeneron to invest $70m in NYC manufacturing
November 15, 2012Manufacturing and Production NY, Regeneron, Sanofi, US
Regeneron has confirmed it will invest almost $70 million to expand its manufacturing in New York City in a move …
Hunt: England to be technology ‘leader’
November 15, 2012Medical Communications, Sales and Marketing Jeremy Hunt, NHS, telehealth
Technology is to free 100,000 people next year from what health secretary Jeremy Hunt calls the ‘constant merry-go-round’ of doctors’ …
Lundbeck opens first Asian manufacturing plant
November 14, 2012Manufacturing and Production China, Lundbeck
Lundbeck has officially opened its first manufacturing facility in China and says it plans to launch three new drugs there …
Germany dismisses Seroquel XR
November 14, 2012Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR
AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …
No specific targets in NHS mandate
November 14, 2012Sales and Marketing CCGs, NHS, commissioning
The government has given the first public directive to the nascent NHS Commissioning Board, which assumes its new responsibilities from …
Eugene Washington appointed to J&J Board of directors
November 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eugene Washington, J&J, JJ
Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …
AstraZeneca signs genome deal
November 13, 2012Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP
AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …
EFCG calls for mandatory inspection of API plants
November 13, 2012Manufacturing and Production API, EFCG, EU, FMD
The European Fine Chemicals Group (EFCG) has called for all active pharmaceutical ingredient (API) manufacturing facilities to undergo mandatory inspections. …
Hospira on track to return propofol to market
November 13, 2012Manufacturing and Production Ball, Hospira, Teva
Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …
NHS Commissioning Board appoints Patients and Information directors
November 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Coulthard, NHS, NHS Commissioning Board
The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
